Agios Pharmaceuticals
AGIO
AGIO
171 hedge funds and large institutions have $3.07B invested in Agios Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 60 increasing their positions, 54 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
11% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 54
2% more funds holding
Funds holding: 167 → 171 (+4)
0.5% less ownership
Funds ownership: 95.68% → 95.18% (-0.5%)
Holders
171
Holding in Top 10
5
Calls
$23.8M
Puts
$19.6M
Top Buyers
| 1 | +$30.5M | |
| 2 | +$16.8M | |
| 3 | +$16.4M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$16M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$15M |
Top Sellers
| 1 | -$35M | |
| 2 | -$22M | |
| 3 | -$20.1M | |
| 4 |
AC
Ascend Capital
Orinda,
California
|
-$19.7M |
| 5 |
AG
Artal Group
Luxembourg
|
-$16.7M |